Community-acquired pneumonia (inpatient, non-ICU)
Adults · verify locally
Inpatient
First line
- Ceftriaxone + azithromycin · i.v./p.o.
Ceftriaxone 1–2 g IV daily + azithromycin 500 mg IV/PO daily
Alternatives
- Ampicillin/sulbactam + macrolide · i.v.
Amp/sulb 1.5–3 g IV q6h + azithromycin 500 mg daily
- Levofloxacin / moxifloxacin · i.v./p.o.
Levofloxacin 750 mg IV/PO daily; or moxifloxacin 400 mg daily
Duration
≥5 days; stop after clinical stability ≥48–72 h
- • IDSA/ATS CAP (2019)
